Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Business

Business

DaVita’s yearly profit prediction is being raised due to the high demand for renal dialysis services.

Listen to the article now

image credit:wikipedia

The aftermarket share price for healthcare provider DaVita increased 3% on Tuesday after the firm boosted its profit prediction for 2024. The business is expecting high demand for its kidney dialysis services.
Like its competitors, DaVita saw a precipitous drop in October of last year, but the stock has since recovered somewhat in 2024 as the business has played down concerns that new GLP-1 weight-loss medications may reduce demand for dialysis.

The Colorado-based company’s revised adjusted per-share profit target for 2024 is $9.25 to $10.05, up from $9.00 to $9.80.
According to LSEG statistics, analysts have estimated an annual per-share profit of $9.32.
In the US, the business serves people with chronic renal failure by way of a system of outpatient clinics and home dialysis.

After applying for and receiving interest-free finance from UnitedHealth, DaVita reported that the Change Healthcare outage continued to cause claims processing delays well into 2024.
The business beat analysts’ expectations for the quarter, reporting $3.19 billion in revenue.
Analysts had predicted $2.54 per share in earnings for the quarter, but the company recorded $2.59 per share after adjustments.

 


Comment Template

You May Also Like

Business

MSG Networks has returned to Optimum after a nearly two-month blackout, restoring Knicks and Rangers coverage for frustrated fans. The new deal places MSG...

Business

Alphabet has introduced **Premium Lite**, a lower-cost YouTube subscription offering ad-free videos (excluding music). This move aims to expand YouTube’s subscriber base and reduce...

Business

India has been named the best solo travel destination for 2025 by Kensington, thanks to its rich culture, history, and diverse experiences. From the...

Business

Warren Buffett's Berkshire Hathaway has aggressively sold stocks, amassing a record $334 billion in cash. Major divestments include Apple and Bank of America, while...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok